scholarly journals The Use of a Percutaneous Closure Device for Closure of an Accidental Puncture of the Aortic Arch; a Simple Solution for a Difficult Problem

2006 ◽  
Vol 32 (1) ◽  
pp. 94-96 ◽  
Author(s):  
V.J. Leijdekkers ◽  
H.L.S. Go ◽  
D.A. Legemate ◽  
J.A. Reekers
Keyword(s):  
Aortic Arch ◽  
Difficult Problem ◽  
Percutaneous Closure ◽  
Simple Solution ◽  
Closure Device

scholarly journals Percutaneous closure of iatrogenic anterior mitral leaflet perforation: a case report

2020 ◽  
Vol 4 (4) ◽  
pp. 1-5
Author(s):  
Hesham Abdo Naeim ◽  
Osama Amoudi ◽  
Abeer Mahmood ◽  
Reda Abuelatta
Keyword(s):  
Heart Surgery ◽  
Open Heart Surgery ◽  
Left Ventricular ◽  
Percutaneous Closure ◽  
The Body ◽  
Closure Device ◽  
Amplatzer Septal Occluder ◽  
Mitral Leaflet ◽  
Anterior Mitral Leaflet ◽  
Septal Occluder Device

Abstract Background Severe mitral regurgitation (MR) through the body of the anterior mitral leaflet (AML) is rare. The cause either iatrogenic during open-heart surgery or due to infective endocarditis. We present a case where a successful percutaneous closure of the AML perforation was an alternative to surgery. Case summary A 60-year-old male presented with shortness of breath (SOB) class III of 12 months duration. He underwent coronary artery bypass surgery with four grafts plus mitral valve (MV) repair 20 months ago. Transthoracic echocardiogram (TTE) and transoesophageal echocardiogram (TOE) revealed severe MR through the body of AML at A3. The percutaneous closure plan was to cross the AML perforation from the left ventricular side. The venacontracta of the perforation was 6 mm, an amplatzer septal occluder device 6 mm considered appropriate for closure of this hole. A snare catheter snared the wire and exteriorized creating arteriovenous loop. Amplatzer septal occluder 6 mm loaded to the delivery system till larger disc (left-sided) opened safely and freely below the MV apparatus. Once the left ventricular side disc opposed the ventricular surface of AML, the waist and left atrial disc gently released. The patient discharged in the next day. After 6 months, the patient had no more SOB, he returned to his daily activity. Follow-up TTE showed no MR, the closure device was stable in place. Discussion We added a successful case of transcatheter AML perforation to the literature. The role of TOE is crucial in diagnosis and procedure guidance.

scholarly journals High-grade atrioventricular block occurring during percutaneous closure of patent foramen ovale: a case report

2020 ◽  
Vol 4 (4) ◽  
pp. 1-5
Author(s):  
Marion Kibler ◽  
Halim Marzak ◽  
Laurence Jesel ◽  
Patrick Ohlmann
Keyword(s):  
Atrioventricular Block ◽  
Patent Foramen Ovale ◽  
Atrioventricular Node ◽  
Percutaneous Closure ◽  
Right Atrial ◽  
Closure Device ◽  
High Grade ◽  
Foramen Ovale ◽  
Conduction Disturbances ◽  
Pfo Closure

Abstract Background  Percutaneous closure of patent foramen ovale (PFO) is recommended for patients presenting with PFO-related stroke. Acute high-grade conduction disturbances occurring during PFO closure procedure have not been previously reported. Case summary  We describe for the first time a case of reversible complete atrioventricular block which occurred during closure of a PFO. Discussion  We hypothesized that the block was the result of atrioventricular node compression—likely caused by the right-atrial disc of the 35-mm PFO closure device. We suggest implanting smaller devices in order to prevent atrioventricular conduction disturbances.

The Safety and Efficacy of a Percutaneous Closure Device in Patients Undergoing Uterine Artery Embolization

2005 ◽  
Vol 16 (3) ◽  
pp. 347-351 ◽  
Author(s):  
Howard B. Chrisman ◽  
David M. Liu ◽  
James T. Bui ◽  
Scott A. Resnick ◽  
Kent Sato ◽  
...  
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Percutaneous Closure ◽  
Closure Device ◽  
Artery Embolization ◽  
Safety And Efficacy

scholarly journals Treatment of Common Femoral Artery Pseudoaneurysm: A Novel Approach Utilizing a VASCADE Percutaneous Closure Device

2019 ◽  
Vol 2019 ◽  
pp. 1-4
Author(s):  
Mark Dalvin ◽  
Brandon Dessecker ◽  
Eugene Vitvitsky
Keyword(s):  
Case Report ◽  
Femoral Artery ◽  
Common Femoral Artery ◽  
Percutaneous Closure ◽  
Closure Device ◽  
Thrombin Injection ◽  
Artery Pseudoaneurysm ◽  
Image Guided ◽  
Novel Technique ◽  
Novel Approach

Iatrogenic common femoral artery pseudoaneurysm is a well-known complication to vascular access. Many options, both surgical and nonsurgical, have been implemented as means to treat pseudoaneurysms such as thrombin injection, image-guided compression, and percutaneous closure devices. This case report demonstrates a novel technique using a VASCADE closure device to successfully treat an iatrogenic common femoral pseudoaneurysm.

Percutaneous Closure of a Giant Aortic Pseudoaneurysm with Occlutech Asd Closure Device

2018 ◽  
Vol 121 (8) ◽  
pp. e87-e88
Author(s):  
Uygar Çağdaş Yüksel ◽  
Murat Çelik ◽  
Erkan Yıldırım ◽  
Ali Osman Yıldırım ◽  
Kubilay Karabacak ◽  
...  
Keyword(s):  
Percutaneous Closure ◽  
Closure Device ◽  
Aortic Pseudoaneurysm ◽  
Asd Closure

Histologic and Duplex Comparison of the Perclose and Angio-Seal Percutaneous Closure Devices

Vascular ◽  
2007 ◽  
Vol 15 (1) ◽  
pp. 24-29 ◽  
Author(s):  
Nicholas J. Gargiulo ◽  
Frank J. Veith ◽  
Takao Ohki ◽  
Lawrence A. Scher ◽  
George L. Berdejo ◽  
...  
Keyword(s):  
Flow Velocity ◽  
Vessel Diameter ◽  
Canine Model ◽  
Duplex Sonography ◽  
Percutaneous Closure ◽  
Artery Dissection ◽  
Closure Device ◽  
Jude Medical ◽  
Femoral Arteries ◽  
Time Required

The intravascular and extravascular effects of percutaneous closure devices have not been well studied. We assessed the performance and healing characteristics in dogs of two devices approved by the US Food and Drug Administration. Nine adult male dogs were anesthesized prior to percutaneous access of both femoral arteries with a 6F sheath. All dogs were systemically heparinized to an activated clotting time (ACT) > 250 seconds. Duplex sonography was performed preoperatively to measure vessel diameter and flow velocity. In each dog, one of two devices (Perclose, Abbot Laboratories, Abbott Park, IL or Angio-Seal, St. Jude Medical, St. Paul, MN) was randomly deployed into one of the two femoral arteries. The other device was deployed on the opposite side. Duplex sonography was repeated immediately after deployment and 28 days later to measure changes in vessel diameter and flow velocity. At 28 days, angiography was performed on both femoral arteries before they were removed for histologic evaluation. The time required to excise each vessel reflected the degree of scarring. Hemostasis time for the Angio-Seal device far surpassed the Perclose device (39 ± 7 vs 0 minutes; p < .05). Vessel narrowing was observed only at 28 days after deployment of the Angio-Seal device ( p < .05). Extensive extravascular scarring was observed with the Angio-Seal device, which resulted in a longer femoral artery dissection time and greater periadventitial scar thickness compared with the Perclose device ( p < .05). When compared with the Perclose suture closure device, the Angio-Seal collagen plug closure device prolonged hemostasis time and produced greater vessel narrowing and periadventitial inflammation (extravascular scarring) in a canine model at 4 weeks.

Sign in / Sign up

Export Citation Format

Share Document